
VA Tech Researchers Explore New Peptide Drug for Brain Cancer
Rob Gourdie, the Heywood Fralin professor at the Fralin Biomedical Research Institute, developed the JM2 peptide with his laboratory while at the Medical University of South Carolina. “When we tested JM2 in glioblastoma stem-like cells, that was the most …